Status:

UNKNOWN

Comparative Study of Gene-activated Bone Substitute and Xenogenic Bone Matrix in Alveolar Ridge Augmentation

Lead Sponsor:

Histograft Co., Ltd.

Collaborating Sponsors:

Moscow State University of Medicine and Dentistry

Conditions:

Alveolar Bone Loss

Alveolar Ridge Pathology | Gingiva | Dental

Eligibility:

All Genders

18-70 years

Brief Summary

The study aim is to compare the effectiveness of two bone substitutes, the gene-activated bone substitute based on octacalcium phosphate and plasmid DNA encoding VEGFA gene and xemogenic deproteinized...

Detailed Description

An open-label randomized controlled clinical trial, two cohort. Patients who met the inclusion criteria is planned to be enrolled into the trial. On enrollment, all patients will have screening, a set...

Eligibility Criteria

Inclusion

  • partial or full edentulism;
  • alveolar ridge atrophy and defects preventing from dental implant placement;
  • obtained voluntary informed consent for participation in the clinical study

Exclusion

  • disability or unwillingness to give a voluntary informed consent or follow requirements of the clinical trial;
  • plaque index (PI) score \> 15%;
  • gingival sulcus bleeding index (SBI) \> 10%
  • decompensated chronic diseases;
  • alcohol addiction;
  • a history of drug addiction;
  • a history of medication with drugs affecting bone tissue metabolism;
  • participation in other clinical trials (or the administration of investigational products) within 3 months prior to the study;
  • conditions limiting study compliance (e.g., dementia, psycho-neurological diseases, drug addiction, and alcoholism);
  • pregnancy or lactation

Key Trial Info

Start Date :

July 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2021

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04511689

Start Date

July 1 2020

End Date

August 1 2021

Last Update

August 13 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Moscow, Russia, 127473

Comparative Study of Gene-activated Bone Substitute and Xenogenic Bone Matrix in Alveolar Ridge Augmentation | DecenTrialz